Who are Vitamin D pill supplementation's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Vitamin D3 as "BABY D3", Vitamin D supplement, Daily Vitamin D3, Liquid Vitamin D, Placebo capsule (Vitamin K1).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vitamin-d-pill-supplementation.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Vitamin D pill supplementation — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin D pill supplementation (Vitamin D pill supplementation) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin/nutritional supplement. Area: Nutritional supplementation / Bone health / Immunology.

marketed Vitamin/nutritional supplement Vitamin D receptor (VDR) Nutritional supplementation / Bone health / Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin D pill supplementation (Vitamin D pill supplementation) — CHU de Quebec-Universite Laval. Vitamin D supplementation increases circulating 25-hydroxyvitamin D levels to support calcium homeostasis, bone health, and immune function.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Vitamin D pill supplementation TARGET	Vitamin D pill supplementation	CHU de Quebec-Universite Laval	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Vitamin D3 as "BABY D3"	Vitamin D3 as "BABY D3"	Rambam Health Care Campus	marketed	Vitamin/Nutritional supplement	Vitamin D receptor (VDR)
Vitamin D supplement	Vitamin D supplement	Aga Khan University	marketed	Vitamin/Nutritional supplement	Vitamin D receptor (VDR)
Daily Vitamin D3	Daily Vitamin D3	Medical University of South Carolina	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Liquid Vitamin D	Liquid Vitamin D	University of California, San Francisco	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Placebo capsule (Vitamin K1)	Placebo capsule (Vitamin K1)	University of Sydney	phase 3	Vitamin/Nutritional supplement	Gamma-glutamyl carboxylase (GGCX)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin/nutritional supplement class)

CHU de Quebec-Universite Laval · 1 drug in this class
Medical University of South Carolina · 1 drug in this class
University of California, San Francisco · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin D pill supplementation — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-d-pill-supplementation. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab